JPMorgan Assumes Moderna (MRNA) at Neutral
JPMorgan analyst Jessica Fye assumes coverage on Moderna (NASDAQ: MRNA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
